- Previous Rank28
- Revenue 3 Yr Annual Growth Rate25%
- Revenue 3 Yr Growth Rank61
- EPS 3 Yr Annual Growth Rate65%
- EPS 3 Yr Growth Rank25
- Total Return 3 Yr Annual Rate23%
- Total Return 3 Yr Rank54
Growth in its DNA: The world’s largest genetic sequencing company is launching a startup, Grail, to develop blood-based screenings for early cancer detection.
Company Information
Location | San Diego, Calif. |
Industry | Pharmaceuticals |
Sector | Health Care |
Current Streak | 2 |
Years on List | 4 |
CEO | Francis deSouza |
Website | http://www.illumina.com |
Revenue, Net Income
Revenue Past Four Quarters ($M) | $2,253 |
Net Income Past Four Quarters ($M) | $414 |
Growth Rates and Ranks
Revenue 3 Yr Growth Rank | 61 |
EPS 3 Yr Annual Growth Rate | 65% |
EPS 3 Yr Growth Rank | 25 |
Total Return 3 Yr Annual Rate | 23% |
Total Return 3 Yr Rank | 54 |